Clinical Review

Vibrio vulnificus: Review of Mild to Life-threatening Skin Infections 

Author and Disclosure Information

Vibrio vulnificus is a motile, gram-negative, halophilic, aquatic bacterium that is part of the normal estuarine microbiome and typically is found in warm coastal waters. Infection with the pathogen typically is due to consumption of contaminated seafood or exposure to contaminated seawater. Vibrio vulnificus has a mortality rate of almost 33% in the United States and is responsible for more than 95% of seafood-related deaths in the United States. Vibrio vulnificus can cause a vast spectrum of diseases, such as gastroenteritis, cellulitis, necrotizing fasciitis, and sepsis. Gastroenteritis is self-limited, whereas septicemia often is fatal. Gastroenteritis and septicemia are caused by ingestion of contaminated shellfish, whereas wound infections and necrotizing fasciitis are caused by exposure to contaminated seawater or handling of contaminated seafood. Septicemia is the most common presentation of V vulnificus and accounts for the most fatalities from the bacteria. Prompt diagnosis and treatment are vital to prevent mortality. It is important to keep V vulnificus on the differential when a patient presents with bullae or cellulitis or has a history of raw seafood consumption or exposure to brackish water, as missing the diagnosis could lead to necrotizing fasciitis, sepsis, and death.

Practice Points

  • Vibrio vulnificus infection should be high on the differential for patients who present with chronic liver disease and immunosuppression; a history of raw seafood consumption or exposure to brackish water; and bullae, cellulitis, necrotic lesions, or sepsis.
  • Time to treatment is directly proportional to mortality rates in V vulnificus infections, and prompt treatment with antibiotics, wound care, debridement, and supportive measures is necessary to decrease mortality rates.
  • The incidence of V vulnificus infection is rising in the United States, likely due to a combination of factors, including an aging population with multiple comorbidities, improvements in diagnosis, and climate change.


 

References

Vibrio vulnificus is a member of the Vibrio genus. Most Vibrio species are nonpathogenic in humans; however, V vulnificus is one of the pathogenic strains.1 In Latin, the term vulnificus means “wounding,” and V vulnificus can cause life-threatening infections in patients. The mortality rate of V vulnificus infections is approximately 33% in the United States.2Vibrio vulnificus is a gram-negative bacterium that was first isolated by the Centers for Disease Control and Prevention in 1964 and was given its current name in 1979.3-6 It has been found in numerous organisms, including oysters, crabs, clams, shrimp, mussels, mullets, and sea bass.4 The vast majority of infections in the United States are due to oyster exposure and consumption.2,7Vibrio vulnificus is responsible for more than 95% of seafood-related deaths in the United States and has the highest mortality rate of all food-borne illness in the United States.2,5 It also has the highest per-case economic impact of all food-related diseases in the United States.1

What distinguishes a pathogenic vs nonpathogenic Vibrio isolate remains unknown; Vibrio species rapidly undergo horizontal gene transfer, making DNA isolation difficult.1 Some characteristics of V vulnificus that may confer virulence are the capsular polysaccharide, lipopolysaccharide, binding proteins, and tissue-degrading enzymes.1,5 First, encapsulated strains are more virulent and invasive than unencapsulated strains.1 The mucopolysaccharide capsule protects the bacterium from the immune system, allowing it to evade immune surveillance, cause more severe infection, and invade into the subcutaneous tissue.3,5 Second, production of sialic acid–like molecules alter the lipopolysaccharide, allowing for motility and biofilm formation.1 This allows the bacterium to survive in marine waters and within the bloodstream, the latter leading to sepsis in humans. Third, production of N-acetylglucosamine–binding protein A allows for adhesion to chitin. Shellfish consume chitin, and chitin accumulates in shellfish. N-acetylglucosamine–binding protein A also binds mucin; this may be how V vulnificus binds to mucin in the gastrointestinal tract in humans, causing gastroenteritis.1 Binding to the human mucosae also may allow the bacteria to gain access to the blood supply, leading to septicemia.4 Finally, tissue-degrading enzymes such as proteases are responsible for necrotizing wound infections associated with V vulnificus, as the enzymes allow for invasion into the skin and subcutaneous tissues. Proteases also increase vascular permeability and lead to edema.3 Hence, these virulence factors may provide V vulnificus the pathogenicity to cause infection in humans.

Three biotypes of V vulnificus have been discovered. Biotype 1 is the most common and is found worldwide in brackish water.8 It can cause the entire spectrum of illnesses, and it has a case fatality rate of 50% in humans. Biotype 1 is presumably responsible for all infections in the United States. Biotype 2 is found in the Far East and Western Europe; it inhabits a unique niche—saltwater used for eel farming. It typically causes infection in eels, but rarely it can cause wound infections in humans. Biotype 3 is found in freshwater fish farming in Israel, and it is a hybrid of biotypes 1 and 2.It can cause severe soft tissue infections in humans, sometimes requiring amputation.8

Epidemiology

Vibrio vulnificus is a motile, gram-negative, halophilic, aquatic bacterium.1,4,5,8,9 It is part of the normal estuarine microbiome and typically is found in warm coastal waters.1,5,10 The ideal conditions for growth and survival of V vulnificus are water temperatures at 18 °C (64.4 °F) and water salinities between 15 to 25 parts per thousand.2,8,9 These conditions are found in tropical and subtropical regions.2Vibrio vulnificus is found all over the world, including Denmark, Italy, Japan, Australia, Brazil, and the United States,2 where most infections come from oyster exposure and consumption in the Gulf of Mexico.2,8,11 The incidence of infection in the United States is highest between April and October.8,11

Some populations are at a higher risk of infection. Risk factors include male sex, liver cirrhosis, hemochromatosis, end-stage renal disease, immunosuppression, and diabetes mellitus.1,8,11 Healthy patients with no risk factors account for less than 5% of US V vulnificus infections.8

Male Predilection
Men are 6 times more likely to be affected by V vulnificus than women.Some hypotheses for this discrepancy are that estrogen is protective againstV vulnificus and that women may be less likely to engage in risky water activities and seafood handling.5 Additionally, older males (aged >60 years) are most often affected,1,8 likely due to the association between increasing age with number of comorbidities, such as diabetes mellitus, heart disease, and chronic disease.8

Iron Levels
Iron appears to play an important role in V vulnificus infection. Iron is essential for bacterial growth, and the ability to obtain iron from a host increases the organism’s pathogenicity.3Vibrio vulnificus rapidly grows when transferrin saturation exceeds 70%.8 Additionally, iron overload decreases the inoculum needed to cause sepsis in animal studies, which could play a role in human pathogenesis.4 Iron levels are elevated in patients with hemochromatosis due to increased iron absorption, cirrhosis and chronic liver disease due to impaired iron metabolism, and end-stage renal disease, especially in patients receiving parenteral iron.8

Pages

Recommended Reading

Reimbursement for Teledermatology During the COVID-19 Public Health Emergency: Change Has Come, But Will It Stay?
MDedge Dermatology
Home Phototherapy During the COVID-19 Pandemic
MDedge Dermatology
Cutaneous Manifestations of COVID-19
MDedge Dermatology
Rheumatologic disease activity an important influencer of COVID-19 death risk
MDedge Dermatology
U.K. COVID-19 variant doubling every 10 days in the U.S.: Study
MDedge Dermatology
Expert calls for paradigm shift in lab monitoring of some dermatology drugs
MDedge Dermatology
2021 ACIP adult schedule released
MDedge Dermatology
Scrub Typhus in Chile
MDedge Dermatology
Multifocal Annular Pink Plaques With a Central Violaceous Hue
MDedge Dermatology
One-third of health care workers leery of getting COVID-19 vaccine, survey shows
MDedge Dermatology